| Meta-analysis of serotonin transporter gene promoter polymorphism (5-HTTLPR) association with antidepressant efficacy S Porcelli, C Fabbri, A Serretti European Neuropsychopharmacology 22 (4), 239-258, 2012 | 396 | 2012 |
| Pharmacogenetics of antidepressant response S Porcelli, A Drago, C Fabbri, S Gibiino, R Calati, A Serretti Journal of Psychiatry and Neuroscience 36 (2), 87-113, 2011 | 237 | 2011 |
| Pharmacogenetics in major depression: a comprehensive meta-analysis T Niitsu, C Fabbri, F Bentini, A Serretti Progress in Neuro-Psychopharmacology and Biological Psychiatry 45, 183-194, 2013 | 221 | 2013 |
| Novel antipsychotics specificity profile: A clinically oriented review of lurasidone, brexpiprazole, cariprazine and lumateperone F Corponi, C Fabbri, I Bitter, S Montgomery, E Vieta, S Kasper, S Pallanti, ... European Neuropsychopharmacology 29 (9), 971-985, 2019 | 151 | 2019 |
| Clinical factors predicting treatment resistant depression: affirmative results from the European multicenter study A Kautzky, M Dold, L Bartova, M Spies, GS Kranz, D Souery, ... Acta Psychiatrica Scandinavica 139 (1), 78-88, 2019 | 142 | 2019 |
| Pharmacogenetics of antidepressants C Crisafulli, C Fabbri, S Porcelli, A Drago, E Spina, D De Ronchi, ... Frontiers in pharmacology 2, 6, 2011 | 137 | 2011 |
| Results of the European Group for the Study of Resistant Depression (GSRD)—basis for further research and clinical practice L Bartova, M Dold, A Kautzky, C Fabbri, M Spies, A Serretti, D Souery, ... The World Journal of Biological Psychiatry 20 (6), 427-448, 2019 | 123 | 2019 |
| Genetics of resilience: Implications from genome‐wide association studies and candidate genes of the stress response system in posttraumatic stress disorder and depression S Maul, I Giegling, C Fabbri, F Corponi, A Serretti, D Rujescu American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183 …, 2020 | 118 | 2020 |
| Pharmacogenetics of antidepressant drugs: an update after almost 20 years of research C Fabbri, G Di Girolamo, A Serretti American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 162 …, 2013 | 118 | 2013 |
| Genetic and clinical characteristics of treatment-resistant depression using primary care records in two UK cohorts C Fabbri, SP Hagenaars, C John, AT Williams, N Shrine, L Moles, ... Molecular Psychiatry 26 (7), 3363-3373, 2021 | 108 | 2021 |
| Genetic polymorphisms of cytochrome P450 enzymes and antidepressant metabolism S Porcelli, C Fabbri, E Spina, A Serretti, D De Ronchi Expert opinion on drug metabolism & toxicology 7 (9), 1101-1115, 2011 | 105 | 2011 |
| Effect of cytochrome CYP2C19 metabolizing activity on antidepressant response and side effects: Meta-analysis of data from genome-wide association studies C Fabbri, KE Tansey, RH Perlis, J Hauser, N Henigsberg, W Maier, ... European Neuropsychopharmacology 28 (8), 945-954, 2018 | 97 | 2018 |
| Pharmacogenetics of major depressive disorder: top genes and pathways toward clinical applications C Fabbri, A Serretti Current psychiatry reports 17, 1-11, 2015 | 96 | 2015 |
| Consensus paper of the WFSBP Task Force on Genetics: Genetics, epigenetics and gene expression markers of major depressive disorder and antidepressant response C Fabbri, L Hosak, R Mössner, I Giegling, L Mandelli, F Bellivier, S Claes, ... The world journal of biological psychiatry 18 (1), 5-28, 2017 | 95 | 2017 |
| Refining prediction in treatment-resistant depression: results of machine learning analyses in the TRD III sample A Kautzky, M Dold, L Bartova, M Spies, T Vanicek, D Souery, ... The Journal of clinical psychiatry 79 (1), 14989, 2017 | 90 | 2017 |
| Pharmacogenetics of antidepressant response: a polygenic approach J García-González, KE Tansey, J Hauser, N Henigsberg, W Maier, O Mors, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 75, 128-134, 2017 | 85 | 2017 |
| Shared genetics among major psychiatric disorders A Serretti, C Fabbri The Lancet 381 (9875), 1339-1341, 2013 | 81 | 2013 |
| Identifying the common genetic basis of antidepressant response O Pain, K Hodgson, V Trubetskoy, S Ripke, VS Marshe, MJ Adams, ... Biological psychiatry global open science 2 (2), 115-126, 2022 | 77 | 2022 |
| From pharmacogenetics to pharmacogenomics: the way toward the personalization of antidepressant treatment C Fabbri, S Porcelli, A Serretti The Canadian Journal of Psychiatry 59 (2), 62-75, 2014 | 77 | 2014 |
| Genome-wide association study of antidepressant treatment resistance in a population-based cohort using health service prescription data and meta-analysis with GENDEP EM Wigmore, JD Hafferty, LS Hall, DM Howard, TK Clarke, C Fabbri, ... The pharmacogenomics journal 20 (2), 329-341, 2020 | 72 | 2020 |